Cargando…
Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal
Chemoresistance and hence the consequent treatment failure is considerably challenging in clinical cancer therapeutics. The understanding of the genetic variations in chemoresistance acquisition encouraged the use of gene modulatory approaches to restore anti-cancer drug efficacy. Many smart nanopar...
Autores principales: | Eljack, Sahar, David, Stephanie, Faggad, Areeg, Chourpa, Igor, Allard-Vannier, Emilie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486027/ https://www.ncbi.nlm.nih.gov/pubmed/36147518 http://dx.doi.org/10.1016/j.ijpx.2022.100126 |
Ejemplares similares
-
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment
por: Eljack, Sahar, et al.
Publicado: (2022) -
Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells
por: Eljack, Sahar, et al.
Publicado: (2022) -
In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model()
por: Nguyen, Phuoc Vinh, et al.
Publicado: (2022) -
Design and Validation of Nanofibers Made of Self-Assembled Peptides to Become Multifunctional Stimuli-Sensitive Nanovectors of Anticancer Drug Doxorubicin
por: Del Genio, Valentina, et al.
Publicado: (2022) -
Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience
por: Elhassan, Moawia Mohammed Ali, et al.
Publicado: (2023)